Muscular dystrophy is the overarching name for a group of illnesses that progressively cause a reduction in muscle mass and ...

A father of two sons diagnosed with muscular dystrophy is organizing a cornhole tournament this weekend to raise money for ...

Becker Muscular Dystrophy, much like Duchenne Muscular Dystrophy, is a type of genetic disorder that causes progressive muscle weakness and degeneration over time, primarily in males.

Becker Muscular Dystrophy Program Further Reinforced With Positive Data Release . As I noted above, Edgewise Therapeutics was able to report positive results from its phase 2 CANYON study using ...

Edgewise is sponsoring an Industry Forum, “Spotlight on Becker muscular dystrophy: Understanding the lived experience of Becker and clinical advancements with a novel agent.” Only conference ...

U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseases Capricor remains on track for the ...

– Edgewise leadership to discuss these updates on Thursday, June 26 at 8:30 a.m. Eastern Time at a virtual investor event – BOULDER, Colo., June 26, 2025 /PRNewswire/ -- Edgewise Therapeutics ...

Cite this: Tadalafil Relieves Ischemia in Becker Muscular Dystrophy - Medscape - Nov 28, 2012. Authors and Disclosures. Authors and Disclosures Journalist Ricki Lewis, PhD.

Medically reviewed by Brigid Dwyer, MDMedically reviewed by Brigid Dwyer, MD The life expectancy for a person with muscular dystrophy (MD) depends on which type of MD they have. Some people live a ...

Edgewise Therapeutics, Inc.,, a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally administered first-in ...

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference – Company to host an Industry Forum to discuss ...